文献速递垂体与肾上腺疾病糖尿病甲状腺疾病

扩展自身免疫性多内分泌综合征1型的表型与基因型图谱

Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

该研究对俄罗斯全国112例自身免疫性多内分泌综合征1型(APS-1)患者进行临床、免疫和遗传学特征分析,发现小脑共济失调伴假瘤、上睑下垂和视网膜色素变性等少见表型,除1例外所有患者均有干扰素-ω中和自身抗体,芬兰主要突变c.769C>T(p.R257*)占72%等位基因,共发现19种不同突变,其中9种为未知突变。

要点

  • APS-1患者可表现为小脑共济失调伴假瘤、上睑下垂和视网膜色素变性等少见表型。
  • 除1例外所有APS-1患者均检出干扰素-ω中和自身抗体。
  • 芬兰主要突变c.769C>T(p.R257*)占72%等位基因,为俄罗斯最常见突变。

核心结论

  • APS-1的表型和AIRE突变谱得到扩展。
  • 芬兰主要突变是俄罗斯最常见的突变,其频率几乎与芬兰相当。
  • 干扰素抗体检测是APS-1的可靠筛查工具。

研究设计与样本

  • 对俄罗斯全国APS-1队列进行广泛的临床、免疫学和遗传学特征分析。
  • 通过系统调查映射临床组分,筛查血清中与APS-1相关的自身抗体,并通过Sanger测序鉴定AIRE突变。
  • 共纳入112例APS-1患者,为迄今描述的最大队列。

主要发现

  • 仔细表型分析发现小脑共济失调伴假瘤、上睑下垂和视网膜色素变性等额外少见表型。
  • 除1例外所有患者均检出干扰素-ω中和自身抗体。
  • 芬兰主要突变c.769C>T(p.R257*)最常见,存在于72%的等位基因中。
  • 共发现19种不同突变,其中9种为未知突变:c.38T>C(p.L13P)、c.173C>T(p.A58V)、c.280C>T(p.Q94*)、c.554C>G(p.S185*)、c.661A>T(p.K221*)、c.821del(p.Gly274Afs*104)、c.1195G>C(p.A399P)、c.1302C>A(p.C434*)和c.1497del(p.A500Pfs*21)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Autoimmune polyendocrine syndrome type 1 (APS-1) is a rare monogenic autoimmune disease caused by mutations in the autoimmune regulator (AIRE) gene and characterized by chronic mucocutaneous candidiasis, hypoparathyroidism, and primary adrenal insufficiency. Comprehensive characterizations of large patient cohorts are rare. OBJECTIVE: To perform an extensive clinical, immunological, and genetic characterization of a large nationwide Russian APS-1 cohort. SUBJECTS AND METHODS: Clinical components were mapped by systematic investigations, sera were screened for autoantibodies associated with APS-1, and AIRE mutations were characterized by Sanger sequencing. RESULTS: We identified 112 patients with APS-1, which is, to the best of our knowledge, the largest cohort described to date. Careful phenotyping revealed several additional and uncommon phenotypes such as cerebellar ataxia with pseudotumor, ptosis, and retinitis pigmentosa. Neutralizing autoantibodies to interferon-ω were found in all patients except for one. The major Finnish mutation c.769C>T (p.R257*) was the most frequent and was present in 72% of the alleles. Altogether, 19 different mutations were found, of which 9 were unknown: c.38T>C (p.L13P), c.173C>T (p.A58V), c.280C>T (p.Q94*), c.554C>G (p.S185*), c.661A>T (p.K221*), c.821del (p.Gly274Afs*104), c.1195G>C (p.A399P), c.1302C>A (p.C434*), and c.1497del (p.A500Pfs*21). CONCLUSIONS: The spectrum of phenotypes and AIRE mutation in APS-1 has been expanded. The Finnish major mutation is the most common mutation in Russia and is almost as common as in Finland. Assay of interferon antibodies is a robust screening tool for APS-1.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Orlova EM, Sozaeva LS, Kareva MA, et al. Expanding the Phenotypic and Genotypic Landscape of Autoimmune Polyendocrine Syndrome Type 1. J Clin Endocrinol Metab. 2017. PMID: 28911151. doi:10.1210/jc.2017-00139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。